Item 7. Management’s Discussion and Analysis
Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.
Overview
We are a blank check company incorporated as a
Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses. We have not selected any business combination target, and we have not, nor
has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend
to effectuate our initial business combination using cash from the proceeds of our initial public offering (“IPO”) and the sale
of the private placement units, our shares, debt or a combination of cash, shares and debt.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare
for the IPO. Following the IPO, we will not generate any operating revenues until after completion of our initial business combination.
We will generate non-operating income in the form of interest and dividend income on cash and cash equivalents and investments held in
the Trust Account (as defined below) after the IPO. After the IPO, we incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for expenses associated with the search for target opportunities.
For the period from May 20, 2025 (inception) through December 31, 2025,
we had a net income of $585,266 which consists of interest and dividend income earned on the Trust Account and bank account of $1,081,975,
partially offset by loss from operations of $496,709 derived from general and administrative expenses.
Liquidity and Capital Resources
On October 2, 2025, we consummated the IPO of
10,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public
Shares”), at $10.00 per Unit, generating gross proceeds of $100,000,000. Simultaneously with the consummation of the IPO and the
sale of the Units, the Company consummated the private placement (“Private Placement”) of 334,000 units (the “Private Placement
Units”) to AA Mission Sponsor II (the “Sponsor”) at a price of $10.00 per Private Placement Unit, generating gross proceeds
of $3,340,000.
Transaction costs amounted to $4,621,564, consisting
of $1,500,000 of cash underwriting fees, $2,500,000 of deferred underwriting commissions which will be paid on the consummation of the
initial business combination, and $621,564 of other offering costs
On October 9, 2025, the underwriters exercised
their over-allotment option in full to purchase an additional 1,500,000 Units at $10.00 per Unit, generating gross proceeds of $15,000,000.
Simultaneously with the sale of the over-allotment Units, the Company consummated the Private Placement of an additional 26,250 Private
Placement Units to the Sponsor at $10.00 per Private Placement Unit, generating gross proceeds of $262,500.
Transaction costs amounted to $600,000 arising from the sale of the
over-allotment Units, consisting of $225,000 of cash underwriting fees and $375,000 of deferred underwriting commissions which will be
paid on the consummation of the initial business combination.
Upon the closing of the IPO and the Private Placement
(including the effects of the exercise of the over-allotment option), $115,287,500 ($10.025 per Unit) of the net proceeds of the IPO (including
the over-allotment Units) and certain of the proceeds of the Private Placement (including the additional Private Placement Units) were
placed in a trust account (the “Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee. The funds
held in the Trust Account may be invested in U.S. government securities with a maturity of 185 days or less.
17
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest and dividends earned on the Trust Account, to complete our initial
business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial
business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
As of December 31, 2025, we had cash and cash
equivalents of $649,431. We will use these funds primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and
complete a business combination, and to pay taxes to the extent the interest earned on the trust account is not sufficient to pay our
taxes.
We expect our primary liquidity requirements during
that period to include approximately $300,000 for legal, accounting, due diligence, travel and other expenses in connection with any business
combinations; $100,000 for legal and accounting fees related to regulatory reporting requirements; $50,000 for NYSE continued listing;
$170,000 for director and officer liability insurance premiums; $180,000 for office space, administrative, financial and support services;
and $10,000 for other miscellaneous expenses, net of estimated interest and dividend income.
These amounts are estimates and may differ materially
from our actual expenses. If our available funds are not sufficient, we may be unable to continue searching for, or conducting due diligence
with respect to, prospective target businesses.
We do not believe we will need to raise additional
funds following the IPO in order to meet the expenditures required for operating our business. However, if our estimates of the costs
of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the
actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination.
Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated
to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional
securities or incur debt in connection with such business combination.
Going Concern Consideration
In connection with the Company’s assessment of
going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification
(“ASC”) 205-40, “Presentation of Financial Statements - Going Concern,” we have determined that mandatory liquidation,
should we not complete a business combination and an extension of our deadline to do so not be approved by the shareholders of the Company,
and potential subsequent dissolution and the liquidity issue raise substantial doubt about the Company’s ability to continue as a going
concern if it does not complete a business combination.
As of December 31, 2025, the Company had cash
and cash equivalents of $649,431 and a working capital of $503,229. The Company has incurred and expects to continue to incur significant
costs as a publicly traded company, to evaluate business opportunities, and to close on a business combination. Such costs will be incurred
prior to generating any operating revenues. These factors also raise substantial doubt about the Company’s ability to continue as
a going concern within one year after the date that the financial statements are issued.
Management plans to complete a business combination
before the mandatory liquidation date and anticipates that the Company will have sufficient liquidity to fund its operations until then.
However, there can be no assurance that the Company will be able to consummate a business combination within the completion window or
that liquidity will be sufficient to fund operations. The financial statements do not include any adjustments relating to the recovery
of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a
going concern.
18
Related Party Transactions
Founder Shares
On June 10, 2025, the Sponsor paid $25,000 to
cover certain offering costs of the Company in consideration for 2,875,000 Class B ordinary shares of the Company. The Founder Shares
include an aggregate of up to 375,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment
is not exercised in full or in part, so that the Sponsor will collectively own, on an as-converted basis, 20% of the Company’s issued
and outstanding shares after the Initial Public Offering. As of December 31, 2025, there were 2,875,000 Founder Shares issued and outstanding,
of which up to 375,000 Founder Shares were subject to forfeiture if the underwriters’ over-allotment option was not exercised. On October
9, 2025, the underwriters fully exercised the over-allotment and, therefore, 375,000 Class B ordinary shares were not forfeited.
Private Placement
On October 2, 2025, the Company consummated the
Private Placement of 334,000 Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit, generating gross
proceeds of $3,340,000. On October 9, 2025, the Company consummated the Private Placement of an additional 26,250 Private Placement Units
to the Sponsor at $10.00 per Private Placement Unit, generating gross proceeds of $262,500.
Administrative Services Agreement
On September 30, 2025, the Company entered into
an agreement commencing on the October 1, 2025 listing date of the IPO to pay the Sponsor a total of up to $10,000 per month for office
space and administrative and support services. Upon completion of a business combination or its liquidation, the Company will cease paying
these monthly fees. An administration fee of $30,000 was recorded and paid for the period from May 20, 2025 (inception) through December
31, 2025.
Promissory Note
On June 10, 2025, the Sponsor issued an unsecured
promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal
amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2025, or (ii) the closing
of the IPO. As of December 31, 2025, there were no amounts outstanding under the Promissory Note.
Due to Related Party
The Sponsor pays certain costs on behalf of the
Company, with such amounts reflected as due to related party. These amounts are due on demand and non-interest bearing. During the period
from May 20, 2025 (inception) through December 31, 2025, the Sponsor paid certain costs totaling $270,013 on behalf of the Company, of
which $25,000 was paid in exchange for the issuance of the Founder Shares. As of December 31, 2025, the amount due to the related party
was $245,013.
Working Capital Loans
In addition, in order to finance transaction costs
in connection with a business combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes
a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a business combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. Up to $1,500,000 of such Working Capital
Loans may be convertible into private placement-equivalent units at a price of $10.00 per unit at the option of the lender. Such units
would be identical to the Private Placement Units. The terms of such Working Capital Loans by the Sponsor or its affiliates, or the Company’s
officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31,
2025, no Working Capital Loans were outstanding.
19
Other Contractual Obligations
Registration Rights
The holders of (i) Founder Shares, which were
issued in a private placement prior to the closing of the IPO, (ii) Private Placement Units, which were issued in a private placement
simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Units, and (iii) private
placement-equivalent units and the Class A ordinary shares underlying such units that may be issued upon conversion of Working Capital
Loans, have registration rights requiring the Company to register the sale of any securities held by them pursuant to a registration rights
agreement entered into prior to the effective date of the IPO. Pursuant to the registration rights agreement, after the exercise of underwriters’
over-allotment option and assuming $1,500,000 of Working Capital Loans will be converted into private placement-equivalent units, the
Company will be obligated to register up to 3,640,375 Class A ordinary shares and 255,125 warrants. The number of Class A ordinary shares
includes (i) 2,875,000 shares issuable upon conversion of the Founder Shares, (ii) 360,250 shares underlying the Private Placement Units,
(iii) 150,000 shares underlying the working capital units, (iv) 180,125 shares underlying the Private Placement Warrants and (v) 75,000
shares underlying the warrants issued in connection with the working capital units. The number of warrants includes 75,000 working capital
warrants and 180,125 Private Placement Warrants. The holders of these securities are entitled to make up to three registration demands,
excluding short-form demands, that the Company register such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements subsequent to completion of the initial business combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option to purchase up to an additional 1,500,000 Units to cover over-allotments at the IPO price, less the underwriting discounts and
commissions.
The underwriters were entitled to a cash underwriting
discount of $0.15 per Unit, or $1,500,000 in the aggregate (or $1,725,000 if the underwriters’ over-allotment option was exercised in
full), payable upon the closing of the IPO. In addition, the underwriters are entitled to a deferred fee of $0.25 per Unit, or $2,500,000
in the aggregate (or $2,875,000 in the aggregate if the underwriters’ over-allotment option was exercised in full). The deferred fee will
become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a business
combination, subject to the terms of the underwriting agreement.
On October 9, 2025, the underwriters exercised
the over-allotment option in full to purchase an additional 1,500,000 Units at $10.00 per Unit, generating gross proceeds of $15,000,000.
Critical Accounting Estimates
The preparation of financial statements and related
disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date
of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.
As of December 31, 2025, we have not identified any critical accounting policies or estimates.
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations;
Quarterly Results
As of December 31, 2025, we did not have any off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
20
JOBS Act
On April 5, 2012, the JOBS Act was signed into
law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies.
We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or
revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable
to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among
other things: (1) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section
404 of the Sarbanes-Oxley Act; (2) provide all of the compensation disclosure that may be required of non-emerging growth public companies
under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (3) comply with any requirement that may be adopted by the PCAOB
regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the
financial statements (auditor discussion and analysis); and (4) disclose certain executive compensation-related items such as the correlation
between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions
will apply for a period of five years following the completion of this offering or until we are no longer an “emerging growth company,”
whichever is earlier.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 8. Financial Statements and Supplementary Data.
Attached.
Item 9. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure.
None.
21